PhotonPharma Secures $2.5 Million in Seed Funding to Advance Clinical Trial for Ovarian Cancer Treatment

FORT COLLINS, Colo., Aug. 21, 2024 /PRNewswire/ — PhotonPharma, a cutting-edge biopharmaceutical company based in Fort Collins, Colorado, is pleased to announce the successful closing of a $2.5 million seed financing round. This vital funding will support the Phase I clinical trial of…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks